Saturday - September 13, 2025
Georgia State University: Breakthrough Cancer Therapy Moves to Phase 2 Trials
September 09, 2025
ATLANTA, Georgia, Sept. 9 -- Georgia State University issued the following news:

* * *

Breakthrough Cancer Therapy Moves to Phase 2 Trials

Georgia State University startup Da Zen Theranostics has reached a key milestone in developing a targeted treatment with the potential to transform cancer care.

By Noelle Toumey Reetz

A promising cancer therapy developed by Georgia State University researchers and biotech startup Da Zen Theranos . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products